Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by ALDA LUI TAM and YING YUAN.
ALDA LUI TAM
Connection Strength
0.052
YING YUAN
  1. A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy. Sci Transl Med. 2022 04 20; 14(641):eabm6420.
    View in: PubMed
    Score: 0.052
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.